Inventor · disambiguated record
Hua Wang
Also filed as: WANG HUA · WANG HUA-YU LEO · Wang hua-yu
41 granted patents·32 pending applications·58 citations·filing 2002–2025
96Inventor score
Files withSUPERNUS PHARMACEUTICALS INC9CURTANA PHARMACEUTICALS INC8PETRA PHARMA CORP7UNIV TEXAS6LIANG LIKAN4
Top patents by PatentIndex Score
73 records- 0192US8298580B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2010·Granted Oct 30, 2012·12 cites·31 claims
- 0290US11873295B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 16, 2024·3 cites·125 claims
- 0390US8969061B2Compositions, methods and related uses for cleaving modified DNAZHU ZHENYU·Filed 2011·Granted Mar 3, 2015·20 cites·13 claims
- 0488US10660420B2Cosmetic compositionsELC MAN LLC·Filed 2017·Granted May 26, 2020·4 cites·11 claims
- 0585US8663683B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2012·Granted Mar 4, 2014·4 cites·24 claims
- 0682US10227333B2Inhibition of OLIG2 activityCURTANA PHARMACEUTICALS INC·Filed 2016·Granted Mar 12, 2019·3 cites·15 claims
- 0781US11891439B2Antibodies and assays for CCL14ASTUTE MEDICAL INC·Filed 2018·Granted Feb 6, 2024·1 cites·20 claims
- 0881US9533947B2Benzamide compounds and related methods of useUNIV NORTHWESTERN·Filed 2014·Granted Jan 3, 2017·2 cites·5 claims
- 0980US11401243B2Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereofUNIV TEXAS·Filed 2018·Granted Aug 2, 2022·2 cites·5 claims
- 1080US9371277B2Benzamide compounds and related methods of useUNIV NORTHWESTERN·Filed 2013·Granted Jun 21, 2016·2 cites·8 claims
- 1178US2024124569A1Antibodies and assays for ccl14ASTUTE MEDICAL INC·Filed 2023·Application pending·0 cites
- 1277US8298576B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2007·Granted Oct 30, 2012·1 cites·30 claims
- 1375US8889191B2Sustained-release formulations of topiramateLIANG LIKAN·Filed 2010·Granted Nov 18, 2014·1 cites·24 claims
- 1475US8038990B2Compositions and methods for the prevention and removal of biofilms on inert and biological surfacesUNIV OHIO STATE·Filed 2006·Granted Oct 18, 2011·2 cites·35 claims
- 1575US2023271926A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1671US11291286B2Cosmetic compositions with a micro-mesh structureELC MAN LLC·Filed 2020·Granted Apr 5, 2022·0 cites·14 claims
- 1770US2025066485A1USE OF INTEGRIN a5b1 INHIBITORS IN THE TREATMENT OF PULMONARY HYPERTENSION AND HEART FAILUREMORPHIC THERAPEUTIC INC·Filed 2024·Application pending·0 cites
- 1870US2024301427A1Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking DefectsOKLAHOMA MED RES FOUND·Filed 2024·Application pending·0 cites
- 1969US12071409B2Quinoline derived small molecule inhibitors of nicotinamide N-methyltransferase (NNMT) and uses thereofUNIV TEXAS·Filed 2022·Granted Aug 27, 2024·0 cites·30 claims
- 2069US8992989B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Mar 31, 2015·0 cites·20 claims
- 2169US2024051948A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 2268US11691951B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Jul 4, 2023·0 cites·8 claims
- 2368US8877248B1Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2014·Granted Nov 4, 2014·0 cites·20 claims
- 2468US2024383878A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2024·Application pending·0 cites
- 2567US12145913B2Inhibition of Olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2021·Granted Nov 19, 2024·0 cites·6 claims
- 2667US10314790B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2017·Granted Jun 11, 2019·0 cites·25 claims
- 2767US2025144231A1Compositions and methods for localized delivery of cytokines for adoptive cell therapyHARVARD COLLEGE·Filed 2024·Application pending·0 cites
- 2865US9622983B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·0 cites·30 claims
- 2965US9549940B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2016·Granted Jan 24, 2017·0 cites·20 claims
- 3065US2021114991A1Inhibition of olig2 activityCURTANA PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3165US2025249121A1Modified exosomes and methods of useUNIV ILLINOIS·Filed 2023·Application pending·0 cites
- 3264US11590182B2Methods and compositions to modulate antibiotic resistance and gastrointestinal microbiotaOHIO STATE INNOVATION FOUNDATION·Filed 2019·Granted Feb 28, 2023·0 cites·9 claims
- 3363US2023085214A1Methods for labeling and targeting cellsHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 3463US2023014445A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Application pending·0 cites
- 3562US2021016227A1Reverse osmosis system for use with a wellbore and methods of assembling the sameBL TECHNOLOGIES INC·Filed 2020·Application pending·0 cites
- 3661US10660419B2Packaged skin treatment composition and methodELC MAN LLC·Filed 2017·Granted May 26, 2020·0 cites·19 claims
- 3761US9555004B2Sustained-release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2015·Granted Jan 31, 2017·0 cites·15 claims
- 3861US2024182460A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 3960US12031136B2Treatment for skeletal diseases caused by intracellular protein trafficking defectsOKLAHOMA MED RES FOUND·Filed 2018·Granted Jul 9, 2024·0 cites·3 claims
- 4059US12258430B2Compositions and methods for labeling and modulation of cells in vitro and in vivoHARVARD COLLEGE·Filed 2021·Granted Mar 25, 2025·0 cites·18 claims
- 4158US2024018115A1Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of diseasePETRA PHARMA CORP·Filed 2023·Application pending·0 cites
- 4257US9890117B2Benzamide compounds and related methods of useUNIV NORTHWESTERN·Filed 2016·Granted Feb 13, 2018·0 cites·20 claims
- 4357US2008131501A1Enhanced immediate release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4456US11878970B2Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of diseasePETRA PHARMA CORP·Filed 2022·Granted Jan 23, 2024·0 cites·65 claims
- 4556US2024191115A1Silicone-based sealant and methods of forming the sameSAINT GOBAIN CERAMICS·Filed 2023·Application pending·0 cites
- 4655US2024425572A1Antibodies and methods of using thereofREGENXBIO INC·Filed 2022·Application pending·0 cites
- 4754US2015024055A1Enhanced immediate release formulations of topiramateSUPERNUS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 4853US11242323B2Inhibition of OLIG2 activityCURTANA PHARMACEUTICALS INC·Filed 2017·Granted Feb 8, 2022·0 cites·15 claims
- 4953US11014953B2Trigger-activatable metabolic sugar precursors for cancer-selective labeling and targetingUNIV ILLINOIS·Filed 2016·Granted May 25, 2021·0 cites·6 claims
- 5053US10828605B2Reverse osmosis system for use with a wellbore and methods of assembling the sameBL TECHNOLOGIES INC·Filed 2015·Granted Nov 10, 2020·0 cites·3 claims
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hua Wang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →